V. Badireenath Konkimalla

Author

National Institute of Science Education and Research ORCID

Also Known As

B V Konkimalla, Badireenath Konkimalla, Konkimalla, V. Badireenath, V BADIREENATH KONKIMALLA, V Badireenath Konkimalla, V Konkimalla, V. B. Konkimalla, V. Badireenath Konkimalla, V. Badireenath Konkimallaa, V. Konkimalla

114

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

National Institute of Science Education and Research German Cancer Research Center Heidelberg University Savitribai Phule Pune University Homi Bhabha National Institute

About

V. Badireenath Konkimalla is an author at National Institute of Science Education and Research specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.1K
2	Biochemistry	11	12	437
3	Natural Sciences	10	10	516
4	Engineering	4	4	101
5	Health Sciences	3	3	95

V. Badireenath Konkimalla

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs Thomas Efferth, V. Badireenath Konkimalla, Yi‐Fen Wang, Clinical Cancer Research	2008	166
Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO<sub>2</sub>) as Antimycobacterial Agents Satish R. Malwal, Dharmarajan Sriram, Perumal Yogeeswari, Journal of Medicinal Chemistry Pharmaceutical ScienceRelease ProfilesOrganic ChemistryAntimicrobial ChemotherapyChemistry	2011	163
Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1 Gernot Polier, Jian Ding, V. Badireenath Konkimalla, Cell Death and Disease	2011	160
Evidence-based Chinese medicine for cancer therapy V. Badireenath Konkimalla, Thomas Efferth Journal of Ethnopharmacology OncologyTraditional Chinese MedicineEvidence-based Chinese MedicineCancer TreatmentMedicine	2007	146
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate Gerhard Kelter, Daniel Steinbach, V. Badireenath Konkimalla, PLoS ONE Chemoprevention StrategyIron MetabolismRedox BiologyCellular PhysiologyTumor Biology	2007	109
Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells V. Badireenath Konkimalla, Martina Blunder, Bernhard Korn, Nitric Oxide InflammationReactive Nitrogen SpecieCell SignalingMedicineLipid Peroxidation	2008	99
Naringin in Combination with Isothiocyanates as Liposomal Formulations Potentiates the Anti-inflammatory Activity in Different Acute and Chronic Animal Models of Rheumatoid Arthritis Sangeeta Mohanty, Ashish Kumar Sahoo, V. Badireenath Konkimalla, ACS Omega	2020	56
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties Shahid A. Soomro, Tobias Langenberg, Anne Mahringer, Journal of Cellular and Molecular Medicine Novel Artemisinin-like DerivativesMedicinal ChemistryAngiogenesisZebrafish Embryo ModelAntiparasitic Agent	2010	53
Molecular docking and pharmacogenomics of Vinca alkaloids and their monomeric precursors, vindoline and catharanthine Serkan Sertel, Yujie Fu, Yuangang Zu, Biochemical Pharmacology Molecular DockingMolecular PharmacologyMedicinal ChemistryDrug TargetBioorganic Chemistry	2011	51
The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells V. Badireenath Konkimalla, James A. McCubrey, Thomas Efferth Current Cancer Drug Targets Epidermal Growth FactorSignal Transduction PathwaysDownstream Signaling PathwaysImmunologyCell Death	2009	45

Page 1